PAPER Rouch I, Trombert B, Kossowsky MP, Laurent B, Celle S, Ntougou Assoumou G, Roche F, Barthelemy JC
SEARCH RESULTS
331395 RESULTS
PAPER Waring JD, Seiger AN, Solomon PR, Budson AE, Kensinger EA
Memory for the 2008 presidential election in healthy ageing and mild cognitive impairment.
Cogn Emot. 2014 Feb 17; PubMed: 24533684PAPER Kim M, Cho KH, Shin MS, Lee JM, Cho HS, Kim CJ, Shin DH, Yang HJ
Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
Int J Mol Med. 2014 Apr;33(4):870-8. Epub 2014 Feb 13 PubMed: 24535622PAPER Katzenschlager R, Poewe W
Parkinson disease: Intestinal levodopa infusion in PD--the first randomized trial.
Nat Rev Neurol. 2014 Mar;10(3):128-9. Epub 2014 Feb 18 PubMed: 24535462PAPER Burke D
ACP Journal Club. Review: Several brief screening tests detect dementia in older adults; no trials assess effects on patient outcomes.
Ann Intern Med. 2014 Feb 18;160(4):JC12. PubMed: 24534934PAPER Yamashita C, Tomiyama H, Funayama M, Inamizu S, Ando M, Li Y, Yoshino H, Araki T, Ichikawa T, Ehara Y, Ishikawa K, Mizusawa H, Hattori N
The evaluation of polyglutamine repeats in autosomal dominant Parkinson's disease.
Neurobiol Aging. 2014 Jul;35(7):1779.e17-21. Epub 2014 Jan 25 PubMed: 24534762PAPER Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y
Peptide-based therapeutic approaches for treatment of the polyglutamine diseases.
Curr Med Chem. 2014;21(23):2575-82. PubMed: 24533807PAPER Jörg M, Scammells PJ, Capuano B
The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson's Disease.
Curr Med Chem. 2014 Feb 16; PubMed: 24533801Yolande Haydon
GliaCure, IncBOSTON, United States
Drug Appears Safe in Huntington’s; Experts Split on Functional Benefit
RESEARCH NEWS 2014-02-19 Research News On February 18, Prana Biotechnology reported top line results of its Reach2HD Phase 2 clinical trial. This trial investigated the safety and tolerability of PBT2 in patients with Huntington’s disease (HD), a progressive form of neurodegen
PAPER Mosser DM, Edwards JP
Exploring the full spectrum of macrophage activation.
Nat Rev Immunol. 2008 Dec;8(12):958-69. PubMed: 19029990PAPER Gordon S
Alternative activation of macrophages.
Nat Rev Immunol. 2003 Jan;3(1):23-35. PubMed: 12511873PAPER Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL
Identification of a unique TGF-β-dependent molecular and functional signature in microglia.
Nat Neurosci. 2014 Jan;17(1):131-43. Epub 2013 Dec 8 PubMed: 24316888Gary Landreth on Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.
COMMENT In the last decade, there has been a fundamental reevaluation of the origins and biology of microglia. Recent work has provided substantial new understanding about the critical roles these cells play in central nervous system disease and injury. In the pa
Annamaria Costa
United Kingdom
Current Filters
No filters selected